One hundred patients were questioned after metrizamide myelography about the side effects of the examination . The number and type of side effects were tabulated and correlated with investigated region (e.g., cervical , lumbar) and with use of medication (e.g., analgesics, diuretics). The number of side effects, particularly neuropsychologic, were higher than previously reported. The most common side effects were minor meningeal irritations (headache, nausea, dizziness, and vomiting) and were regarded by the patients as inconsequential. All side effects became apparent during the first 24 hr after myelography and all were transitory. The side effects, being minor, should not limit the use of metrizamide for myelography. However, those caring for patients who have undergone the study should be aware of the possible side effects.
Metrizamide has considerably less to xicity than previously used myelographic water-soluble contrast media CDimer-X , Conray meglumine) [1 -6] . Seriou s sid e effects are few considering the large number of examinations perform ed , but th e frequency of minor adverse reactions seems to be simi lar to those with other water-soluble contrast media (Oimer-X, Conray meg lu mine) [7] .
We have often noted neuropsychologic reactions after the use of metrizamid e; however, there are relatively few reports of such re actions [8, 9] . This study wa s designed to record the reactions and other sid e effects after lumbar, thoraci c, and cervical myelography with metrizamide.
Subjects and Methods
Th e subjects were 100 patients admitted from Augu st 10 Oc tober 19 79 to th e neuroradiological department , Ulievii.1 Hospital, Oslo, for metri za mid e mye log raphy . All th e mye lograms on patients adm itted to eith er th e neurological departm ent or neurosurg ica l department in thi s period we re in c luded in th e stud y. Th ere we re 59 men and 41 wo men aged 19-78 years ; most were aged 3 0-59 yea rs.
Lumb ar mye lograph y was perform ed in 72 pati ents , th o rac ic mye lography in seven patients , and ce rvical myelograph y in 20 patients. In one pati ent with a tum or in th e th oracic spin e w ith a comp lete subarachnoid block , co ntrast med ium was injected into bo th th e lumbar and cervical subarachnoid space.
A 22 g auge needle was used for th e spin al pun cture. For lumbar and th oracic in vestigations, the pun ctures were made at th e L2-L3 or L3 -L4 levels. Lateral C1-C 2 p un c tures were used for all c ervical studie s.
In 65 pati ents, 10 ml of metriza mide at a co nce ntrati on of 170 mg Il ml was used for lumbar mye lograph y . In six pati ents w ith a w ide dura l sac, 15 ml of 17 0 mg Il ml was used, and in one pati ent 10 ml of 250 mg Il ml was accidenta ll y used. Investiga tion of the co nu s medullaris was in c luded in all lumbar in vesti gati ons. Lu mbar mye log raphy also routin ely in c lud ed lateral radi ograph s in th e sitting position with ex tension and fl ex ion of t he lu mbar spin e.
For th orac ic mye log raph y , 12 -1 5 ml of metri za mi de at a co nce ntration of 210 mg Il ml was used . Th e contrast medium was all owed to flow from th e lum bar to the th oracocervica l jun cti on. For ce rvica l mye log raph y, 6 -10 ml of metri za mi de at a co nce ntrati on of 300 mg Il ml was ro utinely used . After myelography th e patients were kept rec umbent unti l the nex t morning with th e head of th e bed elevated 15° above the horizo ntal. All patients were interv iewed by the authors before the stud ies were performed . As we ll as informing the patients about the investig ation, we also inform ed them about possible general side effec ts. All pati ents were subsequently interviewed 24 and 4 8 hr after mye lography.
Results
Of the 100 patients, 77 (35 women and 42 men) had side effects after metrizamide mye lography . All the side effects beg an during the day of the examination. Patients without complaints on the first day had no furthe r reactions after 48 hr. Side effects are summarized in table 1.
Headache, Dizzin ess, Nausea, and Vomiting
Forty-three patients had headache on the day of exam ination and 22 the next day. Twelve noted dizziness. Seventeen were nauseated and 11 vomited on the day of examination.
Muscular Pain
Thirty-one of the patients complai ned of muscu lar pain in various parts of the body. The pai n was different from that of the presenting complaints. The lower back and legs were the usual locations, but neck pain was also frequently reported . We interpreted this pain as caused by spinoradicular irritation.
Auditory Symptoms
Two patients noticed a high-frequency tone, and one patient heard bell-ringing for several hours.
Visual Disturbances
The symptoms varied considerably. Hemianopia occurred in one woman and lasted for several hours . Previously in this patient, th is symptom had occurred only in assoc iation with headache. Three patients noticed cloudiness of vision , four saw spots and stripes, and one experienced changes in color vision . One patient had clifficulties in focusing . One hypermetropic patient was able to read his newspaper without glasses for some hours. (Usually without glasses he could only read the largest headlines.) Two patients experi enced dimensional distorsion .
All symptoms were transi ent and lasted for some minutes up to 4-5 hr. None of the pati ents was examined by an ophthalmologist during or after the visual disturbances.
Dysphasia and Dysarthria
One patie nt (referred to later) had, in add ition to co nfusion, amn esia, and hallu cin ations, moderate dysphasia and dysarthria . Three other patients had mild dysarthria during the first 24 hr after mye lograp hy. 
Confusional States and Amnesia
There were two patients with pronounced ne uropsycholog ic symptoms. After thoracic myelography , a 60-year-old man experienced cons iderable confusion in addition to almost complete memory loss for recent and more distant events . He experienced visual and aud itory hallucinations as we ll as dysarthria and dysphasia lasting 24 hr. He recovered completely over the next 24 hr.
A 58-year-old woman became considerably confused after lumbar mye lography. She refused all further examination and treatment and insisted on being discharged . She also developed a generalized allerg ic rash . In a telephone conversation 2 days later she said she felt better and had difficulty in explaining her reactions . The rash persisted for 2 weeks . Four other patie nts had less severe and brief confusional episodes.
Halluc inations
Four pati ents had visual hall ucinations, another had auditory hallucinations only, and another had both visual and auditory hallucinations . The halluc inations lasted betwee n a few minutes and 4 -5 hr.
Depression, Unease, and Anxiety
Twelve patients experienced changes in mood th e day of th e examination . Seven patients had a vague feeling of unease and an xiety, and two of them also fe lt depressed and cried more easily than usual. One patient had an anxiety reac tion . Si x felt depressed and were unusually worred about their illness and what it would mean for them in th e future.
Sleep Disturbances and Nightmares
Twenty-si x patients complained of a restless night after metrizamide myelography. This varied from frequent awaken ings to unpleasant nightmares. Several of the patie nts described being half-asleep with intermittent dreaming . Table 2 shows the frequency and type of side effects according to the type of examination. Of the 20 patients undergoing cervical myelography, 13 had side effects : nine meningeal, four spinorad icular, and five cerebral. All seven patients who had thoracic studies had side effects: si x meningeal and four cerebral. Of the 72 patients having lumbar myelography, 57 had side effects: 42 meningeal, 2 2 spinoradic ular, and 33 c erebral.
Side Effects Related to Region of In vestigation

Side Effects Related to Drug Usage
Routinely we permit the patients to take their usual drugs during myelography. The relationship of the side effec ts to drug usage is shown in tabl e 3 . Of all 100 patients , 63 used various medications, including analgesics and neuroleptic drugs, during myelography and 37 did not. Of the 77 pati ents with side effects , 46 were on medication; of the 23 patients without side effects, 17 used drugs.
Of the patients with side effects, 34 % used neurol eptic drugs; whereas 38 % of the patients without sid e effects were on neuroleptic medication . With few exceptions , the neuroleptic used was levomepromazine in doses of 20 mg / day.
Discussion
Most of the complications after mye lography using watersoluble contrast media can be divided into three groups [1 0 , 11]: (1) meningeal irritation , suc h as headach e, nausea, dizziness, and vomiting ; (2) spinoradic ular symptoms , suc h as radicu lar pain , hyperesthesia , hyper-reflexia, and urinary retention ; and (3) c erebral and spinocerebral symptoms, such as convulsions, hyperrefl ex ia, visu al and auditory disturbances, and confusion.
The meningeal reac tion s (headache, nausea, vomiting, and dizziness) are mainly c aused by the lumbar puncture. The frequ ency of these reactions are related to the size of (43) 4 (17) Nole. -Some patients we re on more than one medication . Numbers in parenth eses are percent ages.
th e needl e, the number of punc tures, and the length of ti me the needle is left in th e subarachnoid space [1 2, 13]. Leakage of cerebrospinal flu id is th e most probable cause of these symptoms which are due to traction or press ure o n the meninges. The number of patients in our investigati on who had symptoms of mening eal irritation corres pond s to those of oth er stud ies [14 -16] . Th e frequenc y of these symptoms after myelography is sim ilar to th ose ex perienced after diagnosti c lumbar puncture [ 12, 13] . The subarac hnoid punc ture, and to a lesser deg ree the neurotoxic effect of the contrast medium , might therefore be mainly responsibl e for these symptoms. Th e spinoradi cular and ce rebral sym ptoms are not seen after an ordin ary spinal pun cture. These symptoms are therefore caused by the neurotoxicity of the contrast materi al. In our patients , side effects became apparent usuall y 4-6 hr after th e examinati on, peaking during the first 24 hr and disappearing durin g th e foll owing 24 hr. Computed tomography after th e intraspinal injecti on of metri zam id e shows th e contrast agent in th e intrac ranial subarac hnoid space with enhance ment of the cortex [ 17] . Th is distributio n of c ontrast material depend s on several fac tors, suc h as the injection site, c ontrast conce ntrati on and amoun t, the patient's positioning , hydrati on , and changes in th e intraabdominal pressure [17] . After th e metri zamide is introdu ced into th e intrac rani al subarac hnoid space, the co nce ntration of corti cal co ntrast material inc reases for the first 12 hr, th en declin es [8] . We attribute the adve rse symptoms to the penetrati on of contrast mate rial from the subarac hnoid space into the co rtical tissue. Th e varying time intervals before th e symptoms appear corresponds to the time necessary for the co ntrast mate rial to circ ul ate through th e intracrani al subarac hnoid space and to penetrate into the cortical substance. Th e wi de variety of symptoms may be caused by different patient positioning as we ll as di ffering intracranial circul ations and local abso rbtion conditio ns.
The number of cerebral side effects in our patient group is high in comparison with previous publications from our department [14 , 18, 19] . The types of patients and examination techniques have not changed since our previous studies describing the side effects of metrizamide. The reason for the high in cidence of side effects might be our detailed questioning of the patients and that we filled out the questionn aire ourse lves, not delegating it to other hospital personel. During th e interviews, the patients were first allowed to spontaneously discuss any possible reactions; wh en we went through a li st of side effects, we avoided direct leading questions. Many patients were reluctant to tell of th eir often marked bizarre perceptions that they knew were unreal. Occasionally they were prompted by neighbouring patients. It was often time-consuming to analyze observations th at the patients thought were irrelevant. A ce rtain amount of denial of these symptoms is therefore possible. Similar to most other investigators, we found a higher rate of sid e effects in women [14] .
There was a higher incidence of sid e effects in the patients with lumbar myelograms as compared to those with cervical myelograms. In comparing the patients who had side effects after cervical myelography with those who had side effects after lumbar myelography, we found that the incidence of meningeal irritation (e.g., headache, dizziness) was lower after ce rvi ca l (9 / 20 , 45%) th an lumbar myelograms (42 / 72 , 58%). Also the in cidence of both spinoradicu lar and cerebral symptoms was lower after cervical (4 / 20,20% and 5 / 20, 25 %) than after lumbar myelograms (22/72 , 30% and 33 / 72, 46%). All seven patients who had thoracic studi es had side effects, but no definite conc lu sio ns can be drawn from thi s small series. The examination technique with thorac ic myelography may cause more intracranial metrizamide dispersion than with other techniques.
Our present patient group is different from many others in th at neuroleptics were not discontinued before the exam ination. Many of the pati ents rece ived phenothi azines in addition to analgesics to reli eve radicular pain . Thi s is in accordan ce with the conclusion reached by an investigation performed in our department in 1978 which showed no correlation between side effects and analgesic and neurolepti c drug usage [18] . Since th en, no preex isting medication is discontinued in our departm ent. Our results confirm th at there is no increase of side effects after metrizamide myelography in pati ents using moderate doses of phenothiazines.
